John C. Cheneval
Corporate Officer/Principal bij CASTLE BIOSCIENCES, INC.
Profiel
John C.
Cheneval is currently working as the Executive Director-Business Development at Castle Biosciences, Inc. Prior to his current position, he worked as the Vice President-Pharma Partnerships at HTG Molecular Diagnostics, Inc. from 2018 to 2021.
He also served as the Executive Vice President-Sales & Marketing at Akers Biosciences, Inc. In terms of education, Mr. Cheneval completed his undergraduate degree at LSU Medical School and Louisiana State University.
Actieve functies van John C. Cheneval
| Bedrijven | Functie | Begin |
|---|---|---|
| CASTLE BIOSCIENCES, INC. | Corporate Officer/Principal | 01-01-2021 |
Eerdere bekende functies van John C. Cheneval
| Bedrijven | Functie | Einde |
|---|---|---|
| HTG MOLECULAR DIAGNOSTICS, INC. | Corporate Officer/Principal | 01-01-2021 |
| MYMD PHARMACEUTICALS, INC. | Sales & Marketing | - |
Opleiding van John C. Cheneval
| Louisiana State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| HTG MOLECULAR DIAGNOSTICS, INC. | Commercial Services |
| CASTLE BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Akers Biosciences, Inc.
 Akers Biosciences, Inc. Medical SpecialtiesHealth Technology Akers Biosciences, Inc. engages in the development, manufacture, and supply of screening and testing products. Its products include clinical diagnostics and safety tests. The company was founded by Raymond Francis Akers, Jr. and Raymond F. Akers, Sr. on March 8, 1989 and is headquartered in New York, NY. | Health Technology |
